Article Information
vol. 25 no. 139 19-28
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 8, 2015
- Accepted December 15, 2015
- Published online February 29, 2016.
Copyright & Usage
Copyright ©ERS 2016. ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Stephen H. Gillespie⇑
- Stephen H. Gillespie, School of Medicine, University of St Andrews, North Haugh, St Andrews, KY16 9TF, UK. E-mail: shg3{at}st-andrews.ac.uk
Funding
EUROPEAN Developing Country Clinical trials Partnership
GrantNo.IP.2007.32011.011TB Alliance
Article usage
Altmetrics
Vol 25 Issue 139
Table of Contents
The role of moxifloxacin in tuberculosis therapy
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Repurposing moxifloxacin
- Early-phase development
- Early-phase clinical studies of moxifloxacin
- Phase III studies of fluoroquinolone-containing regimens for treatment shortening in susceptible TB
- Safety of moxifloxacin-containing regimens
- Observations on the outcome of phase III treatment-shortening trials
- Moxifloxacin in the management of MDR-TB
- New regimens and trials
- Conclusion
- Footnotes
- References
- Figures & Data
- Info & Metrics